glp 1 injection site differences GLP-1 Sites: Where to Inject Safely Does It Matter Where You

Choi_ Nikolai stock.adobe.com News Weight loss and diabetes medication GLP-1 agonists may interfere with cancer imaging, new study finds The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET/CT scans, new research presented at the 38th Annual Congress of the European Association of Nuclear Medicine (EANM'25) has revealed. GLP-1 receptor agonists are now widely prescribed for individuals with type 2 diabetes and weight loss, with a 700% increase in usage reported in the United States between 2019 and 2023

Tracy handles advocacy for the Obesity Action Coalition

Is It Possible To Stop Using GLP-1 Medications

Medicare is not included because the necessary data was not available at the time of this analysis

IQVIA Payer Control Library Coverage Is Broader, but Friction Persists The relative success of diabetes GLP-1s is largely due to more favorable coverage and disease framing

But for now, if you're considering GLP-1 therapy, your best bet is having an honest conversation with a healthcare provider about legitimate options